Related Experiment Video
Updated: Dec 24, 2025

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
Published on: July 2, 2018
Cardiogenic Shock in the Setting of Acute Myocardial Infarction
Navin K Kapur1, Katherine L Thayer1, Elric Zweck1
1TUFTS MEDICAL CENTER, BOSTON, MASSACHUSETTS.
Insights
Cardiogenic shock following acute myocardial infarction is a significant cause of death. Despite advances, mortality rates have not improved, highlighting the need for integrated data and early mechanical support.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) in acute myocardial infarction (AMI) is a critical condition with high morbidity and mortality.
- AMI is the primary cause of CS, accounting for 81% of cases.
- Despite therapeutic advancements, mortality from CS has shown no significant improvement over two decades.
Purpose of the Study:
- To review current understanding and optimal management strategies for cardiogenic shock in acute myocardial infarction.
- To emphasize the importance of integrated diagnostic and therapeutic approaches.
Main Methods:
- Review of existing literature and clinical registries.
- Analysis of hemodynamic and metabolic data for diagnosis and risk stratification.
- Evaluation of acute mechanical circulatory support (MCS) device implementation.
Main Results:
- No significant improvement in CS mortality over the past 20 years.
- Registries provide valuable insights into this complex syndrome.
- Optimal treatment involves integrating hemodynamic and metabolic data.
Conclusions:
- Early evaluation and timely initiation of MCS are crucial.
- An organized, algorithmic approach to decision-making improves patient outcomes.
- Integrated hemodynamic and metabolic data are key for diagnosis, risk stratification, and treatment.
Abstract:
Cardiogenic shock in the setting of acute myocardial infarction remains a major cause of morbidity and mortality. In fact, acute myocardial infarction accounts for 81% of patients in cardiogenic shock. Despite advances in pharmacologic and device-based approaches to support patients with cardiogenic shock, no significant improvement in mortality has been observed over the past 20 years, although multiple registries are providing new insight into this complex syndrome. Key elements for optimal treatment include integration of hemodynamic and metabolic data for diagnosis and risk stratification, early evaluation and appropriate initiation of acute mechanical circulatory support devices, and an organized algorithmic approach to decision making.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Introduction Cardiac Emergencies
Acute Coronary Syndrome III: Diagnostic Studies
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

